• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images signs Chindex as reseller

Article

Carestream Health ships DRX-1Aposense imaging agent detects early cell death

Vital Images signs Chindex as reseller

Chindex International will sell advanced visualization software from Vital Images as part of its China portfolio. Chindex provides healthcare services and medical products to China-based hospitals and clinics, including more than 750 Level 1 trauma centers. Vital Images' software processes CT and MR data into 2D and volumetric images.

Carestream Health ships DRX-1

Wireless, cassette-size digital radiography detectors have begun shipping from Carestream Health as the company fills orders placed several months ago from countries around the world for its new DRX-1. The wireless detector is designed for radiographic exams, including those in general radiology, trauma, and orthopedics. The DRX-1 system minimizes installation costs by integrating this detector with a console, thereby requiring no modifications to existing analog equipment.

Aposense imaging agent detects early cell death

Whether radiation therapy is having the desired effect on brain tumors may be seen with the use of a PET imaging agent, according to data presented last week at the SNM meeting. The PET tracer, F-18 ML-10, developed by Aposense, targets apoptosis (programmed cell death) for molecular imaging and therapy. Eight tumors in seven patients demonstrated baseline images of pretreatment apoptosis, with ML-10 uptake increasing over time within the tumors compared with the nontarget tissue and blood. Following treatment, the signal in irradiated tumors increased nearly twofold, indicating a marked increase in the accumulation of ML-10 in tumors compared with other tissues.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.